{"result": "(\"entity\"<|>GLUCOSA-6-FOSFATASA<|>ORGANIZATION<|>Glucosa-6-fosfatasa is an enzyme complex involved in the metabolism of glucose, specifically in the hydrolysis of glucose-6-phosphate to glucose and inorganic phosphate, crucial for glucose release from liver and kidney cells.)\n##\n(\"entity\"<|>GSDI<|>EVENT<|>GSDI refers to a group of glycogen storage diseases characterized by the deficiency of glucose-6-phosphatase, leading to glycogen accumulation and various metabolic issues.)\n##\n(\"entity\"<|>HÍGADO<|>GEO<|>The liver is an organ where glucose-6-phosphatase is located, playing a key role in glucose metabolism and storage.)\n##\n(\"entity\"<|>RIÑONES<|>GEO<|>The kidneys are organs involved in the metabolism of glucose and are affected by the deficiency of glucose-6-phosphatase.)\n##\n(\"entity\"<|>HEPATOMEGALIA<|>EVENT<|>Hepatomegalia is a condition characterized by the enlargement of the liver, often associated with glycogen accumulation in GSDI.)\n##\n(\"entity\"<|>HIPOGLUCE-MIA<|>EVENT<|>Hipoglucemia refers to low blood sugar levels, a common symptom in patients with GSDI due to impaired glucose release.)\n##\n(\"entity\"<|>ACIDOSIS LÁCTICA<|>EVENT<|>Acidosis láctica is a condition resulting from the accumulation of lactic acid in the body, often seen in GSDI due to metabolic disturbances.)\n##\n(\"entity\"<|>HIPERURICEMIA<|>EVENT<|>Hiperuricemia is a condition characterized by elevated uric acid levels in the blood, which can occur in GSDI patients.)\n##\n(\"relationship\"<|>GSDI<|>GLUCOSA-6-FOSFATASA<|>GSDI is caused by the deficiency of glucose-6-phosphatase, leading to various metabolic issues<|>10)\n##\n(\"relationship\"<|>GLUCOSA-6-FOSFATASA<|>HÍGADO<|>Glucose-6-phosphatase is located in the liver, where it plays a crucial role in glucose metabolism<|>8)\n##\n(\"relationship\"<|>GLUCOSA-6-FOSFATASA<|>RIÑONES<|>Glucose-6-phosphatase is also present in the kidneys, affecting glucose metabolism<|>8)\n##\n(\"relationship\"<|>GSDI<|>HEPATOMEGALIA<|>Hepatomegalia is a common symptom of GSDI due to glycogen accumulation in the liver<|>7)\n##\n(\"relationship\"<|>GSDI<|>HIPOGLUCE-MIA<|>Hipoglucemia is a frequent clinical manifestation of GSDI due to impaired glucose release<|>7)\n##\n(\"relationship\"<|>GSDI<|>ACIDOSIS LÁCTICA<|>Acidosis láctica can occur in GSDI patients due to metabolic disturbances<|>6)\n##\n(\"relationship\"<|>GSDI<|>HIPERURICEMIA<|>Hiperuricemia is often observed in GSDI patients as a metabolic consequence<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: .000 y se here-\ndan con carácter autosómico recesivo, excepto el défi-\ncit de fosforilasa-b-kinasa con herencia ligada al X.\n\nEn este capítulo abordaremos solamente las gluco-\ngenosis que se benefician de un tratamiento nutricio-\nnal específico.\n\n1.2. Déficit de glucosa-6-fosfatasa\n    o glucogenosis tipo I (GSDI)\n\n1.2.1. Fisiopatología y diagnóstico\n\nLa GSDI constituye un grupo de enfermedades pro-\nducidas por la afectación de alguno de los componen-\n\ntes del complejo enzimático glucosa-6-fosfatasa (Glu-\n6Pasa), y que se caracterizan por la acumulación de\nglucógeno e infiltración grasa en hígado y riñones, que\nderiva en hepatomegalia, nefromegalia e hipogluce-\nmia. Aunque clásicamente se describían cuatro subti-\npos (Ia, Ib, Ic y Id), actualmente se diferencian solo dos:\n\n• Ia: Déficit de glucosa-6-fosfato hidrolasa o\n  actividad catalítica (G6Pasa), clásicamente en-\n  fermedad de Von Gierke (gen G6PC, 17q21).\n  Es una de las GSD más frecuentes, con una inci-\n  dencia de 1: 100.000 recién nacidos vivos, y re-\n  presenta el 80% de las GSDI. La G6Pasa se localiza\n  en la membrana del retículo endoplásmico de los\n  hepatocitos, en las células de los túbulos renales y\n  enterocitos, y cataliza la hidrólisis de la Glu-6-P en\n  glucosa libre y fósforo inorgánico, por lo que su\n  déficit impide la liberación de la glucosa desde es-\n  tos tejidos al torrente circulatorio.\n• Ib: Déficit de glucosa-6-fosfato translocasa\n  (G6PT) (gen SLC37A4, 11q23). Representa el\n  20% de las GSDI. La función de la G6PT es trans-\n  portar la Glu-6-P desde el citoplasma al interior\n  de la luz del retículo endoplásmico para su poste-\n  rior hidrólisis y devolver al citoplasma las molécu-\n  las de fósforo inorgánico. SLC37A4 se expresa\n  fundamentalmente en la membrana del retículo\n  endoplásmico de hepatocitos, precursores hema-\n  topoyéticos y células renales, y en menor medida\n  de colon, intestino delgado, músculo esquelético\n  y músculo cardíaco. Los subtipos definidos pre-\n  viamente como Ic y Id quedan englobados en\n  este subgrupo, ya que se ha demostrado que\n  también están producidos por mutaciones de SL-\n  C37A4.\n\nEl fenotipo clínico es similar en la GSDIa y Ib. La ma-\nyoría de las veces los síntomas comienzan a partir de\nlos 4-6 meses de edad, aunque en ocasiones la enfer-\nmedad se manifiesta desde el período neonatal con\nhipoglucemias. La clínica se deriva de la disminución\nde los niveles de glucemia por la interrupción de la li-\nberación de glucosa libre desde el hígado, y la deriva-\nción de sustratos intermedios a partir del exceso de\nGlu-6-P hacia otras rutas metabólicas alternativas,\ncomo la síntesis de lípidos, de purinas o la del ácido\nláctico. La forma de presentación típica suele consistir\nen hepatomegalia, hipoglucemias, acidosis láctica, hiper-\nlipemia e hiperuricemia. No obstante esta enfermedad\ntiene un amplio espectro de manifestaciones que se\ndescriben a continuación:\n\n• Hepatomegalia masiva sin esplenomegalia, por\n  acumulación de glucógeno e infiltración grasa.\n  Los niveles de transaminasas están solo levemen-\n  te elevados sin otros parámetros de disfunción\n  hepática.\n---\n## BLOQUE: HIDRATOS DE CARBONO\n\n- Hipoglucemia de ayuno severa sin cetosis, debida a la disminución de la liberación de glucosa hepática. Aparece tras 2-4 horas sin ingerir alimentos y puede provocar crisis convulsivas, sobre todo en neonatos. Los niveles de glucemia se mantienen a expensas de la ingesta.\n\n- Acidosis láctica, debida a la desviación del exceso de sustratos (Glu-6-P pasa a piruvato mediante la glucólisis) hacia la ruta de la lactato deshidrogenasa.\n\n- Hiperuricemia marcada, sobre todo a partir de la\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}